Watch Demo

South Korea Antidepressant Industry Outlook 2022 - 2026

See how South Korea Antidepressant performed compared to key markets such as Canada, Germany and Spain.

Key Market Indicators

Sales of antidepressant medicines in Korea are projected to reach $265.16 million by 2026, up from $234.85 million in 2021. This growth of 2.2% per year on average has been seen since 2013, with the market expanding by 9% each year. In 2021, Korea was the sixth largest market for antidepressant medicines, behind Australia ($234.85 million). Germany, Spain and Italy followed in second, third and fourth place, respectively.

Marketing Banner

South Korea Antidepressant Market Data and Forecasts

How much will South Korea Antidepressant Market grow to 2026?

Forecast: Antidepressant Medicine Sales in South Korea
Forecast: Anxiolytic Medicine Sales in South Korea
Forecast: Antidepressant Medicine Sales in South Korea
Forecast: Antidepressant Medicine Sales in South Korea
Forecast: Anxiolytic Medicine Sales in South Korea
More in Antidepressant Industry for 2028